Cypris raises $4M to help R&D teams track global innovation

January 19, 2023
5min read

NEW YORK, NY, January 19th, 2023 - Cypris, a research platform for R&D teams, today announced a $4M Series A, led by York IE with notable institutional co-investors, Activate VP, K20 Fund & BlueTree Capital. The investment will enable Cypris to further its mission of helping R&D teams track and analyze global innovation through a single comprehensive platform.

Launched in 2021, the Cypris platform allows users to gain unique insights on technologies and companies from 500M+ live data points from sources like global patents, research papers, market news, and more. Cypris is empowering engineers much like Alphasense does for finance and PitchBook does for venture capital. 

Today, R&D teams rely on misaligned or archaic software and costly service providers to answer pressing questions that can hold a significant impact on their long term product roadmap. Engineering teams are also increasingly tasked with building business cases around the verticals they’re looking to invest in, without being armed with the proper data—a daunting and time consuming task. Cypris releases that time consuming hold, while enabling new innovation discovery, by centralizing multiple disparate datasets in one single location. 

“There are more platform innovations being introduced to markets today than at any point in history, across a wide spectrum of verticals,” said Steve Hafif, founder and CEO, Cypris. “Innovations in AI, blockchain, genomics, GPT, all have the power to drastically alter the evolution of even the most specialized markets. The responsibility of tracking these potentially disruptive technological breakthroughs, in many cases, are falling to R&D leaders. Without the proper tools they’re flying blind.”

Through the platform, users can run queries on virtually any keyword, competitor name or forward-looking concept and receive an automated and interactive report built on the historical and current status of innovation on the field or company. The data is pulled from a large proprietary database that the Cypris team curates and updates daily, which consists of major datasets like research papers, patents, product launch news, and more.

Searches that users perform can be saved into reports and grouped into projects that allow for sharing, collaboration among team members, and monitoring of key events within that space like lawsuits, new product launches, unusual market activity, IPOs, and more. Cypris also ensures competitive behavior and pivotal market movements don’t go unnoticed, to allow R&D teams to build their product roadmaps based on relevant and timely data. 

“We’ve found that Cypris is becoming a core part of an R&D team’s basic research process. Users are spending time at the earliest level of a project to build reports surrounding keywords and competitors within a landscape, then adding robust monitoring links to have updates come to them. This gives teams the chance to develop with confidence, and spend less time on dashboards and more time in the lab,” said Steve. 

Although Cypris currently markets to R&D as it’s core user profile, the platform has also proven to be beneficial for professionals in M&A, business development, finance, and venture capital, as an effective tool for conducting advanced technical inquiries.

"Over the past year, Cypris has generated strong product market fit with large enterprise customers across multiple verticals," said Joe Rackza, co-founder and managing partner, York IE. "This success shows that Cypris is becoming a mission critical tool for R&D and innovation teams. While we believe strongly in the market opportunity, we also know Steve is building the right team to capitalize on it. He has a great grasp on their market, business fundamentals, and how to grow the company." 

Cypris plans to use the new funding to invest deeper into their AI applications to decrease ‘time to insights’ for users and to create new opportunities for innovation discovery through the platform. 

For more information on Cypris, visit their website.

About Cypris:

Cypris is a market intelligence platform built for research and development and innovation teams. Designed to serve as a single ecosystem for global innovation data, the Cypris platform allows users to gain unique insights from 500M+ global data points to answer key questions about their market, competitors, core technologies, and more to support new product development, commercial strategy, and accelerate global innovation. To learn more about Cypris and how they help R&D and innovation teams, visit their website.

Press Contact:

McKenna Cosway

mckennac@cypris.ai

Similar insights you might enjoy

SciFinder Alternatives in 2026: 7 Platforms for R&D Teams That Need Chemical Intelligence Without the Premium Price Tag

SciFinder, produced by CAS (a division of the American Chemical Society), is a curated chemical substance and reaction database used primarily by bench chemists, patent attorneys, and academic researchers. Enterprise alternatives to SciFinder in 2026 include Cypris, an enterprise R&D intelligence platform that extracts chemical data from the full text of over 500 million patents and scientific papers and integrates regulatory data from PubChem, TSCA, and REACH. Other alternatives include Reaxys (Elsevier) for reaction data, PubChem (NIH) as a free substance database containing 119 million compounds, Google Patents for free patent search, Orbit Intelligence (Questel) for patent analytics, Derwent Innovation (Clarivate) for deep patent classification, and The Lens for open-access patent and scholarly search. Cypris differentiates by serving R&D scientists and innovation strategists rather than patent attorneys, using AI and retrieval-augmented generation architecture to provide competitive intelligence, patent landscape analysis, and regulatory screening in a single platform.

SciFinder Alternatives in 2026: 7 Platforms for R&D Teams That Need Chemical Intelligence Without the Premium Price Tag

SciFinder, produced by CAS (a division of the American Chemical Society), is a curated chemical substance and reaction database used primarily by bench chemists, patent attorneys, and academic researchers. Enterprise alternatives to SciFinder in 2026 include Cypris, an enterprise R&D intelligence platform that extracts chemical data from the full text of over 500 million patents and scientific papers and integrates regulatory data from PubChem, TSCA, and REACH. Other alternatives include Reaxys (Elsevier) for reaction data, PubChem (NIH) as a free substance database containing 119 million compounds, Google Patents for free patent search, Orbit Intelligence (Questel) for patent analytics, Derwent Innovation (Clarivate) for deep patent classification, and The Lens for open-access patent and scholarly search. Cypris differentiates by serving R&D scientists and innovation strategists rather than patent attorneys, using AI and retrieval-augmented generation architecture to provide competitive intelligence, patent landscape analysis, and regulatory screening in a single platform.

The Best Chemical Intelligence Platforms for R&D Teams in 2026

The leading chemical intelligence platforms for R&D teams in 2026 include Cypris, Reaxys, Orbit Intelligence, Derwent Innovation, Google Patents, The Lens, and PubChem. Late-stage failures in chemical development programs are frequently caused by incomplete early-stage intelligence rather than flawed science, with common triggers including undiscovered blocking patents, unexpected regulatory changes under frameworks like TSCA and REACH, and competitive developments invisible to narrow scanning tools. The choice of intelligence platform directly affects whether development programs survive to commercialization, because fragmented point tools that cover only patents, or only literature, or only substance data create systematic blind spots that compound across R&D portfolios. Cypris (cypris.ai) is the most comprehensive enterprise option, offering unified access to over 500 million patents and scientific papers through a proprietary R&D ontology, with competitive landscape mapping, patent portfolio analytics, freedom-to-operate assessment, material synthesis trend tracking, and AI-generated intelligence reports through Cypris Q that serve as direct inputs to stage-gate reviews.

The Best Chemical Intelligence Platforms for R&D Teams in 2026

The leading chemical intelligence platforms for R&D teams in 2026 include Cypris, Reaxys, Orbit Intelligence, Derwent Innovation, Google Patents, The Lens, and PubChem. Late-stage failures in chemical development programs are frequently caused by incomplete early-stage intelligence rather than flawed science, with common triggers including undiscovered blocking patents, unexpected regulatory changes under frameworks like TSCA and REACH, and competitive developments invisible to narrow scanning tools. The choice of intelligence platform directly affects whether development programs survive to commercialization, because fragmented point tools that cover only patents, or only literature, or only substance data create systematic blind spots that compound across R&D portfolios. Cypris (cypris.ai) is the most comprehensive enterprise option, offering unified access to over 500 million patents and scientific papers through a proprietary R&D ontology, with competitive landscape mapping, patent portfolio analytics, freedom-to-operate assessment, material synthesis trend tracking, and AI-generated intelligence reports through Cypris Q that serve as direct inputs to stage-gate reviews.

Cypris vs. Perplexity for R&D Research: An Honest Comparison for Enterprise Teams in 2026

Cypris and Perplexity are different categories of research tool optimized for different use cases. Perplexity is a general-purpose AI search engine that synthesizes information from the open web, excelling at breadth, speed, commercial context, and accessibility across all domains. Cypris is an enterprise R&D intelligence platform that searches over 500 million patents, scientific papers, and technical documents through a proprietary R&D ontology, excelling at patent intelligence, source verifiability, technical depth, and structured R&D deliverables. In a January 2026 head-to-head evaluation using a 100-point R&D rubric, Cypris scored 89 out of 100 and Perplexity scored 65 out of 100, with Cypris outperforming on source authority, technical depth, competitive and IP intelligence, and R&D actionability, while Perplexity outperformed on commercial timeline specificity and geographic comprehensiveness. Cypris holds official API partnerships with OpenAI, Anthropic, and Google and meets Fortune 500 enterprise security requirements. Perplexity does not provide direct access to patent databases or structured IP intelligence. Both tools serve legitimate research needs, with Perplexity better suited for exploratory and general business research and Cypris better suited for patent-grounded, security-compliant enterprise R&D intelligence.

Cypris vs. Perplexity for R&D Research: An Honest Comparison for Enterprise Teams in 2026

Cypris and Perplexity are different categories of research tool optimized for different use cases. Perplexity is a general-purpose AI search engine that synthesizes information from the open web, excelling at breadth, speed, commercial context, and accessibility across all domains. Cypris is an enterprise R&D intelligence platform that searches over 500 million patents, scientific papers, and technical documents through a proprietary R&D ontology, excelling at patent intelligence, source verifiability, technical depth, and structured R&D deliverables. In a January 2026 head-to-head evaluation using a 100-point R&D rubric, Cypris scored 89 out of 100 and Perplexity scored 65 out of 100, with Cypris outperforming on source authority, technical depth, competitive and IP intelligence, and R&D actionability, while Perplexity outperformed on commercial timeline specificity and geographic comprehensiveness. Cypris holds official API partnerships with OpenAI, Anthropic, and Google and meets Fortune 500 enterprise security requirements. Perplexity does not provide direct access to patent databases or structured IP intelligence. Both tools serve legitimate research needs, with Perplexity better suited for exploratory and general business research and Cypris better suited for patent-grounded, security-compliant enterprise R&D intelligence.